Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Government, leadership and policy news

Show

From To
Special Report: As Trump rewrites health rules, Pence sees conservative agenda born again

In a sweeping social policy shift, the Trump administration is seeking to remake health rules at home and abroad for women, gay and transgender people, restricting access to abortion, curtailing support for contraception and narrowing the scope of civil rights in healthcare.

Published
02 June 2019
From
Reuters
South Africa: Assessing the Motsoaledi years

Dr Aaron Motsoaledi became South Africa’s Minister of Health 10 years ago, in May 2009. The Motsoaledi years can broadly be judged on two fronts: The response to the HIV epidemic and the functioning of the public healthcare system and its related institutions. The verdicts in these two instances are quite different.

Published
31 May 2019
From
Daily Maverick
Politics & power: Why Zweli Mkhize may be a new dawn for health in South Africa — or not?

Will Ramaphosa’s new health minister wield enough power to bring recalcitrant MECs to heel?

Published
31 May 2019
From
Bhekisisa
India: Investing in ART to treat HIV/AIDS

A new analysis has established that further investment in preventing the spread of HIV/AIDS through ART is one of the 12 best investments that India can make to speed up its achievement of the Sustainable Development Goals.

Published
27 May 2019
From
Deccan Herald
Q&A: Battling HIV PrEP stigma with Rep. Brian Sims

To combat the stigma surrounding PrEP use, Pennsylvania state Rep. Brian Sims, D-Philadelphia, the first openly gay man to be elected to the Pennsylvania legislature, recently shared a photo of himself holding an FTC/TDF pill on Instagram.

Published
24 May 2019
From
Healio
Politics of Death: The End of Brazil’s Department of AIDS

The former Department of STIs, Aids and Viral Hepatitis is now named the “Department of Chronical Illnesses and Sexually Transmitted Diseases”. This is not just a name change: it is the end of Brazil’s Program on HIV/Aids.

Published
23 May 2019
From
Sexuality Policy Watch
Republicans defend drug company in spotlight over HIV medication prices

Republican members of Congress defended Gilead, the leading manufacturer of HIV drugs in the U.S., during a testy hearing Thursday as Democrats blasted the company over the prices of its products.

Published
17 May 2019
From
The Hill
Bolsonaro Cuts Harm Reduction, Escalates Drug War

Largely unreported in English-language news media, Brazilian President Jair Bolsonaro has pulled the plug on government support for harm reduction, instead calling for the promotion of abstinence and a crackdown on people who use and sell drugs.

Published
15 May 2019
From
Filter
A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.

A donation of H.I.V.-prevention drugs from the pharmaceutical giant Gilead could benefit shareholders more than patients.

Published
14 May 2019
From
The New York Times (editorial)
Nigel Farage stands by claim that people with HIV should be banned from UK

Brexit Party leader Nigel Farage has stood by his 2014 claim that people living with HIV should not be able to enter the UK.

Published
12 May 2019
From
Pink News

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.